Trial shows drug effective in nearly 80% of patients with hypertrophic cardiomyopathy

Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.